Making Personalized Cancer Therapies Accessible to All
CSEM has supported Lausanne-based start-up Limula in its mission to make cell therapies more affordable, and to facilitate access to these personalized treatments.
Source: azom.com
Stay updated with breaking news from Single Bioreactor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CSEM has supported Lausanne-based start-up Limula in its mission to make cell therapies more affordable, and to facilitate access to these personalized treatments.